AR131406A1 - Método de ligación de ácidos nucleicos - Google Patents

Método de ligación de ácidos nucleicos

Info

Publication number
AR131406A1
AR131406A1 ARP230103439A ARP230103439A AR131406A1 AR 131406 A1 AR131406 A1 AR 131406A1 AR P230103439 A ARP230103439 A AR P230103439A AR P230103439 A ARP230103439 A AR P230103439A AR 131406 A1 AR131406 A1 AR 131406A1
Authority
AR
Argentina
Prior art keywords
nucleic acid
atp
optionally
vector
domain
Prior art date
Application number
ARP230103439A
Other languages
English (en)
Inventor
Gregory Mann
Frederic Valentin Stanger
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR131406A1 publication Critical patent/AR131406A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1229—Phosphotransferases with a phosphate group as acceptor (2.7.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00—Reaction characterised by the enzymatic activity
    • C12Q2521/50—Other enzymatic activities
    • C12Q2521/501—Ligase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00—Reaction characterised by the enzymatic activity
    • C12Q2521/50—Other enzymatic activities
    • C12Q2521/525—Phosphatase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/04—Phosphotransferases with a phosphate group as acceptor (2.7.4)
    • C12Y207/04001—Polyphosphate kinase (2.7.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y605/00—Ligases forming phosphoric ester bonds (6.5)
    • C12Y605/01—Ligases forming phosphoric ester bonds (6.5) forming phosphoric ester bonds (6.5.1)
    • C12Y605/01001—DNA ligase (ATP) (6.5.1.1)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a métodos de ligación biocatalítica para producir oligonucleótidos; y polipéptidos de fusión para su uso en dichos métodos. En particular, la presente invención se refiere a métodos de ligación biocatalítica que incorporan regeneración de ATP y a polipéptidos de fusión que comprenden un dominio de polifosfato quinasa y un dominio de ligasa de ácido nucleico dependiente de ATP. Reivindicación 1: Un método de producción de un oligonucleótido a partir de dos o más fragmentos de oligonucleótidos, en donde el método comprende poner en contacto: i. dos o más fragmentos de oligonucleótidos; ii. una ligasa de ácido nucleico dependiente de ATP; iii. una polifosfato quinasa (PPK); iv. trifosfato de adenosina (ATP) y/o monofosfato de adenosina (AMP); v. polifosfato; y vi. un catión divalente; por medio de lo cual se proporciona un oligonucleótido. Reivindicación 7: Una composición que comprende: i. una ligasa de ácido nucleico dependiente de ATP; ii. una PPK; iii. ATP y/o AMP; iv. un catión divalente; y v. polifosfato; opcionalmente en donde la composición además comprende dos o más fragmentos de oligonucleótidos. Reivindicación 10: Un polipéptido de fusión que comprende: a) un dominio PPK; y b) un dominio de ligasa de ácido nucleico dependiente de ATP. Reivindicación 13: Una molécula de ácido nucleico que codifica el polipéptido de fusión de la reivindicación 10 o la reivindicación 11; opcionalmente en donde la molécula de ácido nucleico comprende una secuencia de ácido nucleico que tiene por lo menos 85% de identidad de secuencia con la secuencia de ácido nucleico de: (a) cualquiera de las SEQ ID Nº 34 - 36; y/o (b) cualquiera de las SEQ ID Nº 30 - 33 u 87. Reivindicación 14: Un vector que comprende el ácido nucleico de la reivindicación 13; opcionalmente en donde el vector se selecciona entre un plásmido, un cósmido, un bacteriófago o un vector viral. Reivindicación 15: Una célula huésped que comprende la molécula de ácido nucleico de la reivindicación 13 o el vector de la reivindicación 14; opcionalmente en donde la célula huésped es E. coli.
ARP230103439A 2022-12-20 2023-12-18 Método de ligación de ácidos nucleicos AR131406A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP22215207 2022-12-20

Publications (1)

Publication Number Publication Date
AR131406A1 true AR131406A1 (es) 2025-03-19

Family

ID=84901612

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP230103439A AR131406A1 (es) 2022-12-20 2023-12-18 Método de ligación de ácidos nucleicos

Country Status (11)

Country Link
US (1) US20250382650A1 (es)
EP (1) EP4638778A1 (es)
JP (1) JP2025542208A (es)
KR (1) KR20250128321A (es)
CN (1) CN120584194A (es)
AR (1) AR131406A1 (es)
AU (1) AU2023409829A1 (es)
IL (1) IL321536A (es)
MX (1) MX2025007140A (es)
TW (1) TW202440941A (es)
WO (1) WO2024134505A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025262452A1 (en) * 2024-06-18 2025-12-26 Novartis Ag Nucleic acid ligation method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7629157B2 (en) 2003-08-11 2009-12-08 Codexis, Inc. Ketoreductase polypeptides and related polynucleotides
CN1845993B (zh) 2003-08-28 2010-06-23 诺瓦提斯公司 具有平端和3'修饰的干扰rna双链体
GB0608838D0 (en) 2006-05-04 2006-06-14 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
KR20250128321A (ko) 2025-08-27
AU2023409829A1 (en) 2025-07-03
EP4638778A1 (en) 2025-10-29
JP2025542208A (ja) 2025-12-25
MX2025007140A (es) 2025-07-01
IL321536A (en) 2025-08-01
CN120584194A (zh) 2025-09-02
US20250382650A1 (en) 2025-12-18
TW202440941A (zh) 2024-10-16
WO2024134505A1 (en) 2024-06-27

Similar Documents

Publication Publication Date Title
JP2022185083A (ja) 標的rnaを検出するための方法及び組成物
Takemura Poxviruses and the origin of the eukaryotic nucleus
EP3377648B1 (en) Dp04 polymerase variants
JP4473573B2 (ja) 多部位突然変異誘発
JP7023842B2 (ja) Dnaポリメラーゼシータによる核酸の3’末端の修飾
Diekmann et al. The influence of exocyclic substituents of purine bases on DNA curvature.
Pinarbasi et al. Activation of a yeast pseudo DNA methyltransferase by deletion of a single amino acid
US20110171717A1 (en) Method for enhancing polymerase activity
Chan et al. Sequence specificity and biochemical characterization of the RusA Holliday junction resolvase of Escherichia coli
Monnard et al. Eutectic phase in water‐ice: a self‐assembled environment conducive to metal‐catalyzed non‐enzymatic RNA polymerization
US9926542B2 (en) Practical method for enzymatically synthesizing cyclic di-GMP
JP6720632B2 (ja) 融合タンパク質
Fukuoh et al. DNA conformation‐dependent activities of human mitochondrial RNA polymerase
Lad et al. Biochemical reconstitution of the mimiviral base excision repair pathway
Raghavendra et al. Mechanistic insights into type III restriction enzymes
Lebedeva et al. Photoaffinity labeling of proteins in bovine testis nuclear extract
KR920701444A (ko) 이노신-구아노신 키나아제
Kreutzer et al. Footprinting of tRNAPhe transcripts from Thermus thermophilus HB8 with the homologues phenylalanyl-tRNA synthetase reveals a novel mode of interaction
Lu et al. Unique ligation properties of eukaryotic NAD+-dependent DNA ligase from Melanoplus sanguinipes entomopoxvirus
JP4475826B2 (ja) タンパク質の安定化方法
Moen et al. Uracil-DNA glycosylase of Thermoplasma acidophilum directs long-patch base excision repair, which is promoted by deoxynucleoside triphosphates and ATP/ADP, into short-patch repair
Recio et al. Site-directed mutagenesis provides insights into the selective binding of trityl derivatives to Plasmodium falciparum dUTPase
Sharma et al. The balance between the rates of incorporation and pyrophosphorolytic removal influences the HIV‐1 reverse transcriptase bypass of an abasic site with deoxy‐, dideoxy‐, and ribonucleotides
US20100291638A1 (en) Thermostable dna polymerases and methods of use
WO2026089040A1 (ja) Rnaポリメラーゼ変異体